Complaints, returns, and recalls should be recorded and handled carefully in accordance with established procedures. Records should be made available to the competent authorities. An assessment of returned active substances used as starting materials in veterinary medicinal products should be performed before any approval for resale.
Recital 16, Regulation (EU) 2021/1280
In forcesince 2 Aug 2021